Stocks › ARWR
Arrowhead Pharmaceuticals ARWR
US equityMarket cap rank #1888
$41.37 −$2.28 (-5.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $41.40 +0.07%
Open$43.15
Prev close$43.65
Day range$41.17 – $44.80
Volume3.91M
Market cap$5.85B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q4, ended Sep 2026
Revenue$37.79M-85.3% YoY
Operating profit-$436.63M-1,089.9% YoY
Net profit-$428.89M-2,760.4% YoY
Diluted EPS-$3.01-1,572.2% YoY
Free cash flow-$195.83M-1,606.2% YoY
Operating cash flow-$192.40M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin99.6%
Operating margin-156.9%
Net margin-160.6%
Return on equity-280.5%
Return on assets-46.4%
Return on invested capital-73.2%
Current ratio4.14
Liabilities / assets97.1%
Cash & investments$1.19B
Total debt$994.70M
Net cash (debt)$198.29M
Income statement
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $450.82M | $37.79M | $75.25M | $73.74M | $264.03M |
| Total Operating Revenue | $450.82M | $37.79M | $75.25M | $73.74M | $264.03M |
| Cost of Revenue | $1.80M | – | – | – | – |
| Gross Profit | $449.02M | – | – | – | – |
| Operating Expense | $1.16B | $472.62M | $245.35M | $215.00M | $223.22M |
| Selling and Admin Expenses | $200.14M | $66.75M | $46.63M | $41.24M | $45.52M |
| -General & Admin Expense | $200.14M | $66.75M | $46.63M | $41.24M | $45.52M |
| Research & Development | $954.14M | $405.47M | $198.22M | $173.25M | $177.20M |
| Depreciation & Amortization & Depletion | $1.91M | $408,000.00 | $494,000.00 | $500,000.00 | $504,000.00 |
| -Depreciation & Amortization | $1.91M | $408,000.00 | $494,000.00 | $500,000.00 | $504,000.00 |
| Operating Profit | -$707.17M | -$436.63M | -$170.09M | -$141.26M | $40.81M |
| Net Non-Operating Interest Income (Expense) | -$35.84M | -$8.43M | -$7.63M | -$6.98M | -$12.82M |
| Non-Operating Interest Income | $57.86M | $14.37M | $16.94M | $16.87M | $9.69M |
| Non-Operating Interest Expense | $93.71M | $22.80M | $24.56M | $23.85M | $22.51M |
| Other Income (Expense) | $19.10M | $9.34M | -$1.19M | $10.67M | $277,000.00 |
| Earnings from Equity Interest | -$3.88M | $5.31M | -$2.47M | -$6.72M | – |
| Special Income (Charges) | $19.00M | $0.00 | $0.00 | $19.00M | – |
| -Gain on Sale of Property/Plant/Equipment | $19.00M | $0.00 | $0.00 | $19.00M | – |
| Other Non-Operating Income (Expenses) | $3.98M | $4.03M | $1.29M | -$1.61M | $277,000.00 |
| Pretax Profit | -$723.92M | -$435.71M | -$178.91M | -$137.57M | $28.27M |
| Tax | -$6.78M | -$6.83M | $11,000.00 | $7,000.00 | $29,000.00 |
| Net Profit | -$717.13M | -$428.89M | -$178.92M | -$137.57M | $28.24M |
| Profit from Continuing Operations | -$717.13M | -$428.89M | -$178.92M | -$137.57M | $28.24M |
| Minority Interests | $7.07M | -$884,000.00 | $15.36M | -$4.84M | -$2.57M |
| Net Income to Parent Company | -$724.21M | -$428.00M | -$194.28M | -$132.73M | $30.81M |
| Net Income to Common Stockholders | -$724.21M | -$428.00M | -$194.28M | -$132.73M | $30.81M |
| Basic EPS | -$5.11 | -$3.01 | -$1.36 | -$0.93 | $0.22 |
| Diluted EPS | -$5.11 | -$3.01 | -$1.36 | -$0.93 | $0.22 |
Balance sheet
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total Assets | $1.74B | $1.74B | $2.11B | $2.27B | $1.60B |
| Total Current Assets | $1.29B | $1.29B | $1.67B | $1.84B | $1.17B |
| Cash and Cash Equivalents & Short-Term Investments | $1.19B | $1.19B | $1.60B | $1.78B | $916.61M |
| -Cash and Cash Equivalents | $62.74M | $62.74M | $19.69M | $147.53M | $71.37M |
| -Short Term Investments | $1.13B | $1.13B | $1.58B | $1.64B | $845.24M |
| Receivables | $9.93M | $9.93M | $8.56M | $15.69M | $218.87M |
| -Accounts Receivable | $9.93M | $9.93M | $8.56M | $15.69M | $218.87M |
| Prepaid Assets | $31.58M | $31.58M | $25.37M | $21.72M | $16.05M |
| Inventory | $9.08M | $9.08M | – | – | – |
| Other Current Assets | $45.65M | $45.65M | $35.52M | $18.25M | $22.86M |
| Total Non-Current Assets | $449.04M | $449.04M | $440.60M | $428.51M | $429.79M |
| Net PPE | $429.65M | $429.65M | $428.97M | $417.62M | $421.95M |
| -Gross PPE | $533.33M | $533.33M | $526.21M | $508.90M | $508.09M |
| -Accumulated Depreciation | -$103.68M | -$103.68M | -$97.24M | -$91.29M | -$86.15M |
| Goodwill and Other Intangible Assets | $5.16M | $5.16M | $5.59M | $6.01M | $6.44M |
| -Other Intangible Assets | $5.16M | $5.16M | $5.59M | $6.01M | $6.44M |
| Other Non-Current Assets | $14.23M | $14.23M | $6.05M | $4.89M | $1.41M |
| Total Liabilities | $1.69B | $1.69B | $1.65B | $1.67B | $1.04B |
| Total Current Liabilities | $311.34M | $311.34M | $283.35M | $295.22M | $347.43M |
| Payables | $30.15M | $30.15M | $29.89M | $32.86M | $84.35M |
| -Accounts Payable | $30.15M | $30.15M | $27.78M | $30.75M | $32.94M |
| -Total Tax Payable | $0.00 | $0.00 | $0.00 | $0.00 | $10.89M |
| Current Accrued Expenses | $137.04M | $137.04M | $107.52M | $94.84M | $92.94M |
| Short-Term Debt and Capital Lease Obligation | $45.50M | $45.50M | $45.32M | $47.77M | $47.53M |
| -Current Debt | $40.00M | $40.00M | $40.00M | $40.00M | $40.00M |
| -Current Capital Lease Obligation | $5.50M | $5.50M | $5.32M | $7.77M | $7.53M |
| Current Deferred Liabilities | $91.65M | $91.65M | $94.60M | $108.54M | $111.93M |
| Other Current Liabilities | $7.01M | $7.01M | $6.02M | $11.21M | $10.68M |
| Total Non-Current Liabilities | $1.38B | $1.38B | $1.36B | $1.37B | $694.06M |
| Long Term Debt and Capital Lease Obligation | $954.70M | $954.70M | $938.37M | $941.69M | $265.24M |
| -Long Term Debt | $838.88M | $838.88M | $824.07M | $841.58M | $163.11M |
| -Long Term Capital Lease Obligation | $115.81M | $115.81M | $114.30M | $100.11M | $102.13M |
| Non-Current Deferred Liabilities | $21.34M | $21.34M | $31.74M | $48.62M | $53.83M |
| Other Non-Current Liabilities | $400.38M | $400.38M | $392.51M | $383.83M | $375.00M |
| Total Equity | $50.50M | $50.50M | $466.04M | $598.92M | $562.70M |
| Stockholders' Equity | $50.31M | $50.31M | $465.53M | $613.98M | $568.42M |
| Capital Stock | $237,000.00 | $237,000.00 | $237,000.00 | $236,000.00 | $233,000.00 |
| -Common Stock | $237,000.00 | $237,000.00 | $237,000.00 | $236,000.00 | $233,000.00 |
| Additional Paid-In Capital | $2.46B | $2.46B | $2.44B | $2.40B | $2.21B |
| Retained Earnings | -$2.35B | -$2.35B | -$1.92B | -$1.73B | -$1.60B |
| Less: Treasury Stock | -$53.19M | -$53.19M | -$53.19M | -$53.19M | -$53.19M |
| Gains/Losses Not Affecting Retained Earnings | -$7.65M | -$7.65M | -$1.23M | $742,000.00 | $6.70M |
| Minority Interests | $191,000.00 | $191,000.00 | $512,000.00 | -$15.06M | -$5.73M |
| -Dividends Payable | – | – | $2.11M | $2.11M | $40.52M |
Cash flow
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$271.95M | -$192.40M | -$177.47M | $84.44M | $13.48M |
| Net cash flow from continuing operations | -$271.95M | -$192.40M | -$177.47M | $84.44M | $13.48M |
| Net Income from Continuing Operations | -$717.13M | -$428.89M | -$178.92M | -$137.57M | $28.24M |
| Gain/Loss from Continuing Operations | -$14.72M | -$4.87M | $2.45M | -$12.28M | -$19,000.00 |
| Depreciation & Depletion & Amortization | $26.62M | $7.21M | $6.66M | $6.37M | $6.39M |
| Other Non-Cash Items | $307.20M | $237.13M | $23.82M | $23.74M | $22.51M |
| Change in Working Capital | $60.90M | -$19.95M | -$45.51M | $188.15M | -$61.79M |
| -Change in Receivables | -$3.29M | -$1.38M | $6.95M | $203.19M | -$212.05M |
| -Change in Inventory | -$9.08M | – | – | – | -$451,000.00 |
| -Change in Prepaid Assets | -$57.10M | -$27.16M | -$21.53M | $4.77M | -$13.18M |
| -Change in Payables and Accrued Expense | $29.77M | $35.00M | $3.83M | -$10.83M | $1.76M |
| -Change in Other Current Liabilities | -$4.54M | -$982,000.00 | -$1.13M | -$1.21M | -$1.21M |
| -Change In Other Working Capital | $105.13M | -$16.36M | -$33.63M | -$8.21M | $163.34M |
| Net cash flow from investing | -$670.48M | $203.86M | $43.68M | -$894.28M | -$23.74M |
| Net Cash Flow from Continuing Investing Activities | -$670.48M | $203.86M | $43.68M | -$894.28M | -$23.74M |
| Net PPE Purchase and Sale | -$12.00M | -$3.43M | -$3.85M | -$2.57M | -$2.15M |
| Net Investment Purchase and Sale | -$443.49M | $422.29M | $47.54M | -$891.72M | -$21.59M |
| Net Other Investing Changes | -$215.00M | – | – | – | – |
| Financing Cash Flow | $776.82M | -$3.70M | -$449,000.00 | $795.72M | -$14.75M |
| Net Cash Flow from Continuing Financing Activities | $776.82M | -$3.70M | -$449,000.00 | $795.72M | -$14.75M |
| Net Issuance Payments Of Debt | $578.52M | -$133.59M | -$33.39M | $812.17M | -$66.68M |
| Net Common Stock Issuance | $206.11M | $130.00M | $27.95M | $1.32M | $46.83M |
| Proceeds from Stock Option Exercised | $114.73M | $1.97M | $2.62M | $105.05M | $5.10M |
| Net Other Financing Charges | -$122.55M | -$2.09M | $2.37M | – | – |
| Ending Cash Balance | $62.74M | $62.74M | $54.76M | $188.52M | $201.64M |
| Net Change in Cash | -$165.61M | $7.76M | -$134.24M | -$14.12M | -$25.01M |
| Beginning Cash Balance | $226.55M | $54.76M | $188.52M | $201.64M | $226.55M |
| Effect of Exchange Rate Changes | $1.80M | $220,000.00 | $477,000.00 | $997,000.00 | $106,000.00 |
| Free Cash Flow | -$283.94M | -$195.83M | -$181.32M | $81.88M | $11.33M |
No comments yet — be the first to weigh in on ARWR.
Sign in to join the discussion.